Welcome to our dedicated page for Cannabist news (Ticker: CBSTF), a resource for investors and traders seeking the latest updates and insights on Cannabist stock.
The Cannabist Company Holdings Inc. reports developments tied to its U.S. cannabis cultivation, manufacturing and retail operations. The company, formerly known as Columbia Care, serves medical and adult-use markets through the Cannabist retail brand and product lines that include flower, edibles, oils and tablets.
Recurring news for CBSTF includes material agreements with senior noteholders, capital-structure updates involving senior secured and senior secured convertible notes, operating and financial results, governance matters and cannabis regulatory disclosures. Company updates also reference branded products such as Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press and Amber.
The Cannabist Company (OTCQB: CBSTF) entered definitive agreements to sell its Ohio and Delaware cannabis businesses and signed a non‑binding MoU for remaining markets, while commencing CCAA proceedings in Canada and planning Chapter 15 recognition in the U.S.
Key monetary terms: $130M Virginia sale closed, Ohio sale $47M (incl. $12.5M note), Delaware sale $16.5M, and the Company paused operations in New York and is winding down Pennsylvania operations.
The Cannabist Company (OTCQB: CBSTF) said an ad hoc group of holders of its 9.25% Senior Secured Notes and 9.00% Senior Secured Convertible Notes agreed to further extend forbearance. The noteholders will forbear from exercising remedies under the indenture and applicable law until March 25, 2026.
The extension preserves the existing forbearance framework for a short, defined period while parties consider next steps.
The Cannabist Company (OTCQB: CBSTF) announced that its ad hoc group of noteholders agreed to further extend the existing forbearance agreement and will forbear from exercising rights under the indenture until March 17, 2026.
The extension covers the Company’s 9.25% Senior Secured Notes due December 31, 2028 and 9.00% Senior Secured Convertible Notes due December 31, 2028, deferring creditor remedies for the specified period.
The Cannabist Company (OTCQB: CBSTF) said an ad hoc group of holders of its 9.25% Senior Secured Notes due December 31, 2028 and 9.00% Senior Secured Convertible Notes due December 31, 2028 agreed to further extend their forbearance.
According to the company, noteholders will forbear from exercising rights and remedies under the indenture and applicable law until March 6, 2026.
The Cannabist Company (OTCQB: CBSTF) said an ad hoc group of holders of its 9.25% Senior Secured Notes and 9.00% Senior Secured Convertible Notes agreed to further extend a forbearance and will forbear from exercising remedies under the indenture and applicable law until February 27, 2026.
The extension preserves the company’s temporary protection from noteholder enforcement while parties continue negotiations through the new forbearance date.
The Cannabist Company (OTCQB: CBSTF) said an ad hoc group of noteholders agreed to extend a forbearance agreement and will forbear from exercising remedies under the amended indenture governing its 9.25% and 9.00% senior secured notes.
The forbearance extension runs until February 20, 2026, covering both note series due December 31, 2028.
The Cannabist Company (OTCQB: CBSTF) closed the previously announced sale of its Virginia operating subsidiary to an affiliate of Millstreet for $130 million.
The consideration included $117.5 million cash at closing and a $12.5 million offset escrow with staged releases and post-closing purchase price adjustments. The Virginia assets include five active retail stores, one store in development, and ~82,000 sq ft of cultivation and production capacity.
The company issued partial redemption notices for its 2028 secured notes and expects to redeem roughly $84.488 million of 9.25% notes and $6.469 million of 9.00% convertible notes on February 13, 2026.
The Cannabist Company (OTCQB: CBSTF) entered a forbearance agreement with an ad hoc group holding >75% of its 9.25% and 9.00% senior secured notes. The company elected not to pay interest due December 31, 2025 to preserve liquidity after announcing a Virginia asset sale. The forbearance pauses remedies until February 17, 2026 while parties pursue strategic alternatives; no assurance of extension or agreement exists.
The Cannabist Company (OTCQB: CBSTF) agreed to sell all ownership interests of Green Leaf Medical of Virginia to an affiliate of Millstreet for $130 million total consideration, subject to adjustment. The assets include 5 active retail locations, 1 location in development, and ~82,000 sq ft of cultivation/production capacity in Richmond.
Consideration comprises $117.5M cash at closing and a $12.5M offset escrow; Buyer deposited $23.7M into escrow after signing. Closing is expected early 2026, subject to regulatory approvals and post-closing purchase-price adjustments. The company plans to use part of proceeds to redeem notes.
The Cannabist Company (OTCQB: CBSTF) agreed to sell its Virginia cannabis business to a Curaleaf subsidiary for total consideration of $110 million, subject to adjustment. The assets include 5 active retail locations, 1 retail location in development, and ~82,000 sq ft of cultivation and production in the Richmond region.
Deal terms: $80M cash at closing, $20M deferred cash tied to adult-use sales timing, and a $10M promissory note/b at 6% interest maturing one year after closing. The EPA includes a 15-business-day go-shop through , a $3.3M break fee, and customary closing conditions including regulatory approvals and Noteholder Consent. Expected to close early 2026; proceeds planned partly to redeem outstanding notes.